Envestnet Asset Management »

Apellis Pharmaceuticals shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $956k 44k 21.87
2024-12-31 $892k 28k 31.91
2024-09-30 $4.5M 156k 28.84
2024-06-30 $5.2M 135k 38.36
2024-03-31 $5.6M 95k 58.78
2023-09-30 $3.1M 81k 38.04
2023-06-30 $1.9M 21k 91.10
2023-03-31 $1.4M 21k 65.96
2022-09-30 $280k 4.1k 68.23

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Core Total Usd (IUSB)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr S&p 500 Val Etf (IVE)
NVIDIA Corporation (NVDA)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)

View all positions for Envestnet Asset Management

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
Jennison Associates
State Street Corporation
EcoR1 Capital
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
Geode Capital Management

View all funds holding Apellis Pharmaceuticals